Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Optima Health plc (OPT.L)
GBp192.50
+1.00 (+0.52%)
GB LSE Healthcare Medical - Care Facilities
Address
Meadow Court
Sheffield, GB
Sheffield, GB
CEO
Jonathan David Thomas
Website
optimahealth.co.uk
IPO
2024-09-26
ISIN GB00BRSCY602
Description
Optima Health Plc specializes in delivering workplace health and employee wellbeing solutions. Their extensive range of offerings includes initiatives for engagement and overall wellness, alongside dedicated services for mental health and musculoskeletal care. Established in 1947, the company's main office is situated in Sheffield, United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
GBp192.50
+1.00 (+0.52%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
224.6K
Beta
-0.58
Float Shares
51.29M
Free Float %
57.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.80% | +0.27% | +4.76% | -5.56% | -6.97% | -3.11% | +23.84% | +23.84% | +23.84% | +23.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
192.50
DCF (Unlevered)
311.83
+62.0%
DCF (Levered)
159.49
-17.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-5.3%
-
EPS growth Medical - Care Facilities: +19.2%+368.3% ★
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+0.3% Q3'25: +9.7%
-
EBIT margin Medical - Care Facilities: +11.3%+3.1% Q3'25: +3.3%
-
ROIC Medical - Care Facilities: +6.8%+1.2% Q3'25: +4.2%
-
Share dilution Medical - Care Facilities: +0.0%-42.1% ★
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.59× ★ Q3'25: 0.64×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 2 EPS Ana. |
Mar 2027 2 Rev. Ana. 1 EPS Ana. |
Mar 2028 2 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
105.05M
est: 105.00M (+0.0%)
|
123.02M
122.70M – 123.20M
+17.2% YoY
|
181.09M
179.21M – 182.97M
+47.2% YoY
|
202.19M
200.10M – 204.29M
+11.7% YoY
|
160.39M
158.73M – 162.05M
-20.7% YoY
|
| EBITDA |
13.65M
est: 10.35M (+31.9%)
|
12.13M
12.10M – 12.15M
+17.2% YoY
|
17.85M
17.67M – 18.04M
+47.2% YoY
|
19.93M
19.73M – 20.14M
+11.7% YoY
|
15.81M
15.65M – 15.98M
-20.7% YoY
|
| EBIT |
3.24M
est: 252.7K (+1,182.4%)
|
296.0K
295.2K – 296.5K
+17.2% YoY
|
435.7K
431.2K – 440.3K
+47.2% YoY
|
486.5K
481.5K – 491.6K
+11.7% YoY
|
385.9K
381.9K – 389.9K
-20.7% YoY
|
| Net Income |
1.65M
est: 5.68M (-70.9%)
|
6.42M
6.05M – 6.79M
+13.1% YoY
|
7.01M
6.75M – 7.27M
+9.1% YoY
|
8.71M
8.59M – 8.83M
+24.3% YoY
|
10.58M
10.44M – 10.72M
+21.5% YoY
|
| SGA |
19.57M
est: 18.82M (+4.0%)
|
22.05M
21.99M – 22.08M
+17.2% YoY
|
32.46M
32.12M – 32.80M
+47.2% YoY
|
36.24M
35.87M – 36.62M
+11.7% YoY
|
28.75M
28.45M – 29.05M
-20.7% YoY
|
| EPS |
0.03
est: 0.11 (-70.9%)
|
0.12
0.12 – 0.13
+10.9% YoY
|
0.14
0.13 – 0.14
+11.2% YoY
|
0.17
0.17 – 0.17
+24.3% YoY
|
0.21
0.20 – 0.21
+21.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
Ownership data is not available for this company yet.
Executive team
Top executives
EBIT / Employee
2.1K
Shares Outstanding
88.87M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jonathan David Thomas | Chief Executive Officer & Director | 344.0K | male |
| Heidi Giles | Chief Financial Officer & Director | 148.0K | female |
| Noel Leo McElearney | Chief Medical Officer | — | — |
| Ruth Jane Weanie | Human Resources Director | — | — |
| Victoria Hargreaves | Governance, Risk and Compliance Director | — | female |
| Martin Paxton | Chief Information Officer | — | male |
| Brenda Orelu | Legal Director & Secretary | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OPT.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
